These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Antigen specific B cells in myasthenia gravis patients. Takata K; Kinoshita M; Mochizuki H; Okuno T Immunol Med; 2020 Jun; 43(2):65-71. PubMed ID: 32046601 [TBL] [Abstract][Full Text] [Related]
27. Sarcoglycan Alpha Mitigates Neuromuscular Junction Decline in Aged Mice by Stabilizing LRP4. Zhao K; Shen C; Li L; Wu H; Xing G; Dong Z; Jing H; Chen W; Zhang H; Tan Z; Pan J; Xiong L; Wang H; Cui W; Sun XD; Li S; Huang X; Xiong WC; Mei L J Neurosci; 2018 Oct; 38(41):8860-8873. PubMed ID: 30171091 [TBL] [Abstract][Full Text] [Related]
28. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase]. Maruyama N; Shigemoto K Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813 [TBL] [Abstract][Full Text] [Related]
29. Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis. Mori S; Motohashi N; Takashima R; Kishi M; Nishimune H; Shigemoto K Exp Neurol; 2017 Nov; 297():158-167. PubMed ID: 28823823 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic and clinical classification of autoimmune myasthenia gravis. Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233 [TBL] [Abstract][Full Text] [Related]
31. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent. Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288 [TBL] [Abstract][Full Text] [Related]
32. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects. Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541 [TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in Japanese patients with ocular myasthenia gravis. Nagaishi A; Narita T; Woodhall M; Jacobson L; Waters P; Irani SR; Vincent A; Matsuo H Muscle Nerve; 2021 Feb; 63(2):262-267. PubMed ID: 33094484 [TBL] [Abstract][Full Text] [Related]
35. Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability. Takamori M Front Mol Neurosci; 2020; 13():86. PubMed ID: 32547365 [TBL] [Abstract][Full Text] [Related]
36. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies. Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451 [TBL] [Abstract][Full Text] [Related]
37. Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology. Fichtner ML; Jiang R; Bourke A; Nowak RJ; O'Connor KC Front Immunol; 2020; 11():776. PubMed ID: 32547535 [TBL] [Abstract][Full Text] [Related]
38. [Myasthenia gravis induced by autoantibodies against MuSK]. Shigemoto K; Konishi T; Ohta M Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361 [TBL] [Abstract][Full Text] [Related]
39. Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis. Li Y; Zhang Y; Cai G; He D; Dai Q; Xu Z; Chu L Muscle Nerve; 2017 Nov; 56(5):938-942. PubMed ID: 28120340 [TBL] [Abstract][Full Text] [Related]
40. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis. Cordts I; Bodart N; Hartmann K; Karagiorgou K; Tzartos JS; Mei L; Reimann J; Van Damme P; Rivner MH; Vigneron A; Weis J; Schulz JB; Tzartos SJ; Claeys KG J Neurol; 2017 Jun; 264(6):1193-1203. PubMed ID: 28516329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]